Chronic Low Back Pain Clinical Trial
Official title:
Risk of Poor Prognosis in Patients With Chronic Low Back Pain : Can it be Predicted by Physical Tests and Screening Tools ? - An Observational Study
Verified date | May 2015 |
Source | Université du Québec à Trois-Rivières |
Contact | n/a |
Is FDA regulated | No |
Health authority | Canada: Ethics Review Committee |
Study type | Observational |
The aim of the present study is to quantify the relative contribution of variables obtained during a physical fitness evaluation and a short screening questionnaire in determining the short-term and long term risk of persistent disabling low back pain in patients with chronic low back pain. It has been hypothesized that patients with higher physical fitness will present a lower risk of persistent disabling low back pain and so, a lower score on the questionnaire.
Status | Completed |
Enrollment | 53 |
Est. completion date | September 2014 |
Est. primary completion date | July 2014 |
Accepts healthy volunteers | No |
Gender | Both |
Age group | 18 Years to 60 Years |
Eligibility |
Inclusion Criteria: - adults between 18 and 60 years old - nonspecific low back pain : pain located between the twelfth rib and the inferior gluteal fold for which no specific source of pain could be identified - chronic low back pain : pain present for 12 weeks or more, and included both constant and recurrent patterns of pain - able to read and understand French Exclusion Criteria: - History of surgery or major trauma to the spine - Current use of medication known to impair physical effort and pain perception - Lumbar scoliosis of more than 20° - Collagenosis, severe osteoporosis - Neuromuscular disease - Malignant tumor - Non-controlled hypertension - Infection - Radiculopathy - Progressive neurologic defect - Myelopathy - Lumbar disc hernia - Pregnancy - Active lower body injury and/or severe and disabling pain limiting the capacity to undergo the evaluation. |
Observational Model: Cohort, Time Perspective: Prospective
Country | Name | City | State |
---|---|---|---|
Canada | Université du Québec à Trois-Rivières | Trois-Rivières | Quebec |
Lead Sponsor | Collaborator |
---|---|
Université du Québec à Trois-Rivières | Fonds de la Recherche en Santé du Québec, Institut de Recherche Robert-Sauvé en Santé et en Sécurité du Travail |
Canada,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Disability level | Oswestry disability index | 2 months | No |
Primary | Disability level | Oswestry disability index | 4 months | No |
Primary | Disability level | Oswestry disability index | 6 months | No |
Primary | Disability level | Oswestry disability index | 12 months | No |
Secondary | Pain intensity in the past 2 months | 101 points numerical rating scale | 2 months | No |
Secondary | Fear of movement level | Tampa scale for kinesiophobia | 2 months | No |
Secondary | Patient's global impression of change from baseline | Patient's global impression of change scale | 6 months | No |
Secondary | Patient's global impression of change from 6 months | Patient's global impression of change scale | 12 months | No |
Secondary | Pain intensity in the past 2 months | 101 points numerical rating scale | 4 months | No |
Secondary | Pain intensity in the past 2 months | 101 points numerical rating scale | 6 months | No |
Secondary | Pain intensity in the past 6 months | 101 points numerical rating scale | 12 months | No |
Secondary | Pain intensity in the past week | 101 points numerical rating scale | 12 months | No |
Secondary | Fear of movement level | Tampa scale for kinesiophobia | 4 months | No |
Secondary | Fear of movement level | Tampa scale for kinesiophobia | 6 months | No |
Secondary | Fear of movement level | Tampa scale for kinesiophobia | 12 months | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03243084 -
Transcranial Alternating Current Stimulation in Back Pain- Pilot Sudy
|
N/A | |
Suspended |
NCT04735185 -
Stem Cells vs. Steroids for Discogenic Back Pain
|
N/A | |
Completed |
NCT03162952 -
RAND Center of Excellence for the Study of Appropriateness of Care in CAM
|
||
Completed |
NCT03240146 -
Pulsed Shortwave Therapy Treatment for Chronic Musculoskeletal Low Back Pain
|
N/A | |
Completed |
NCT05282589 -
Lumbopelvic Manipulation Effects on Fatigue in Chronic Low Back Pain Patients
|
N/A | |
Completed |
NCT03637998 -
Physical Activity on Neurophysiologic Gene Expression Profiles of Chronic Low Back Pain
|
N/A | |
Recruiting |
NCT02289170 -
Clinical Study to Evaluate the Safety and Efficacy of Heating and Cooling Combination Therapeutic Device(OCH-S100)
|
N/A | |
Active, not recruiting |
NCT01944163 -
The IMPACT of a Referral Model for Axial Spondyloarthritis in Young Patients With Chronic Low Back Pain
|
N/A | |
Completed |
NCT02231554 -
Feldenkrais vs Back School for Treating Chronic Low Back Pain: a Randomized Controlled Trial
|
N/A | |
Recruiting |
NCT02063503 -
Identification of Prognostic Indicators for Rehabilitation in Chronic Nonspecific Low Back Pain Patients
|
N/A | |
Completed |
NCT01704677 -
Lumbar Disc Prosthesis Versus Multidisciplinary Rehabilitation; 8-year Follow-up
|
N/A | |
Terminated |
NCT01620775 -
MR(Magnetic Resonance) Imaging of Neurotransmitters in Chronic Pain
|
N/A | |
Completed |
NCT01177241 -
Cytochrome P450 Pharmacokinetic DDIs Among Patients With Chronic Low Back Pain Taking Opioids
|
N/A | |
Completed |
NCT01177254 -
Exposure to Potential Cytochrome P450 Pharmacokinetic Drug-Drug Interactions Among Osteoarthritis Patients: Incremental Risk of Multiple Prescriptions
|
N/A | |
Completed |
NCT01490905 -
A Double Blind Placebo Study to Determine the Effectiveness of Theramine on the Management of Chronic Back Pain
|
Phase 4 | |
Completed |
NCT01177280 -
Prevalence of Potential Cytochrome P450 Pharmacokinetic Incident Drug-Drug Interactions Among Chronic Low Back Pain Patients Taking Opioid Analgesics and Associated Economic Outcomes
|
N/A | |
Completed |
NCT00984815 -
Safety Study of HZT-501 in Patients Who Require Long-Term Daily Non-steroidal Anti-inflammatory Drug Treatment
|
Phase 3 | |
Completed |
NCT00761150 -
Study to Evaluate the Safety and Efficacy of ABT-712 in Subjects With Moderate to Severe Chronic Low Back Pain (CLBP)
|
Phase 3 | |
Completed |
NCT00763321 -
Study to Evaluate the Safety and Efficacy of ABT-712 in Subjects With Moderate to Severe Chronic Low Back Pain (CLBP)
|
Phase 3 | |
Completed |
NCT00767806 -
A Study for Patient With Chronic Low Back Pain
|
Phase 3 |